Menu
GWAS Study

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.

Dudenkov TM, Liu D, Cairns J et al.

30648747 PubMed ID
GWAS Study Type
687 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DT
Dudenkov TM
LD
Liu D
CJ
Cairns J
DS
Devarajan S
ZY
Zhuang Y
IJ
Ingle JN
BA
Buzdar AU
RM
Robson ME
KM
Kubo M
BA
Batzler A
BP
Barman P
JG
Jenkins GD
CE
Carlson EE
GM
Goetz MP
ND
Northfelt DW
MA
Moreno-Aspitia A
DZ
Desta Z
RJ
Reid JM
KK
Kalari KR
WL
Wang L
WR
Weinshilboum RM
Chapter II

Abstract

Summary of the research findings

Anastrozole is a widely prescribed aromatase inhibitor for the therapy of estrogen receptor positive (ER+) breast cancer. We performed a genome-wide association study (GWAS) for plasma anastrozole concentrations in 687 postmenopausal women with ER+ breast cancer. The top single-nucleotide polymorphism (SNP) signal mapped across SLC38A7 (rs11648166, P = 2.3E-08), which we showed to encode an anastrozole influx transporter. The second most significant signal (rs28845026, P = 5.4E-08) mapped near ALPPL2 and displayed epistasis with the SLC38A7 signal. Both of these SNPs were cis expression quantitative trait loci (eQTL)s for these genes, and patients homozygous for variant genotypes for both SNPs had the highest drug concentrations, the highest SLC38A7 expression, and the lowest ALPPL2 expression. In summary, our GWAS identified a novel gene encoding an anastrozole transporter, SLC38A7, as well as epistatic interaction between SNPs in that gene and SNPs near ALPPL2 that influenced both the expression of the transporter and anastrozole plasma concentrations.

634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

687
Total Participants
GWAS
Study Type
No
Replicated
European, Asian unspecified, African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.